Add a Comment By Jim Stallard, MA, Writer/Editor   |  Wednesday, October 30, 2013 Medical oncologist Anas Younes leads an ambitious effort to find disease biomarkers that could predict which lymphoma patients will benefit from new targeted therapies. read more

See original article:
On Cancer :: At Work: Anas Younes, Chief of the Lymphoma Service

Scroll to Top